Related Experiment Videos
De novo minimal change disease
G S Markowitz1, C L Stemmer, B P Croker
1Department of Pathology, Columbia Presbyterian Medical Center, New York, NY 10032, USA.
Summary
This study reports a rare case of de novo minimal change disease causing reversible kidney failure in a renal transplant recipient. Strict diagnostic criteria are essential for identifying this uncommon post-transplant complication.
Area of Science:
- Nephrology
- Transplantation Immunology
- Glomerular Diseases
Background:
- Proteinuria in renal allografts can stem from recurrent, transplant-associated, or de novo glomerular diseases.
- Minimal change disease (MCD) is a rare cause of proteinuria and acute kidney injury in renal transplant recipients.
- Accurate diagnosis of de novo MCD requires strict clinical and pathological criteria.
Observation:
- A 56-year-old male patient developed reversible acute renal failure 2.5 years post-renal transplantation.
- The patient's native kidneys had end-stage renal disease due to membranous glomerulopathy.
- The presentation was consistent with de novo minimal change disease in the renal allograft.
Findings:
- De novo minimal change disease is an exceptionally rare complication in renal allografts.
- Previous reports of de novo MCD in renal allografts often do not meet stringent diagnostic criteria.
- This case and a review of eight other cases appear to fulfill strict criteria for de novo MCD.
Implications:
- Accurate diagnosis of de novo MCD is crucial for appropriate patient management and prognosis.
- Understanding the specific criteria for de novo MCD aids in differentiating it from other post-transplant glomerular diseases.
- Further research into the pathogenesis and management of de novo MCD in renal allografts is warranted.